Atlas Trials

Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery

Clinical trial NCT01666210 · COMPLETED

Trial details

NCT number
NCT01666210
Sponsor
Ocular Therapeutix, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ocular Inflammation and Pain
Start date
2012-10-01
Primary completion
2013-08-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.